The Swedish Public Health Agency assesses that the benefits far outweigh the risks of Astra Zeneca's vaccine.
Therefore, the use of the vaccine for people over 65 is resumed.
But why should the vaccine not be given to people under 65?
"Waiting for data"
State epidemiologist Anders Tegnell commented on the decision in tonight's Aktuellt.
- We do not recommend the vaccine for younger people because there are signals of 20-30 cases in Europe.
There are few, but it is a very serious side effect.
We are now waiting for data to see if it can also be offered to younger people, Tegnell said in the broadcast.
If you are over 65 and may have had a previous blood clot, should you take this vaccine then?
- We absolutely mean it.
There is no connection to previous blood clots, but this is a completely different mechanism, said Anders Tegnell.
What do you say to those who hesitate?
- The risk of infection is there.
And the risk of becoming seriously ill.
If there is a risk at all with the vaccine, it is very very small, the vaccine has been given to millions of people.
If this was a common side effect, we would have seen the side effect much more often.